摘要 : Background: The SAPHO syndrome is a relatively rare clinical entity characterized by a wide range of dermatological and musculoskeletal manifestations. Biologics have been used in cases refractory to conventional treatment.
| 作者 | Daoussis~ Dimitrios Konstantopoulou~ Georgia Kraniotis~ Pantelis Sakkas~ Lazaros Liossis~ Stamatis-Nick |
|---|---|
| 作者单位 | |
| 期刊名称 | 《Seminars in Arthritis and Rheumatism》 |
| 总页数 | 8 |
| 语种/中图分类号 | 英语 / R593 |
| 关键词 | SAPHO Treatment Biologics Anti-TNF Infliximab Adalimumab Etanercept Certolizumab Golimumab IL-1 Anakinra Canakinumab IL-17 Secukinumab IL-23 Ustekinumab IL-6 tocilizumab Abatacept Rituximab |
| 馆藏号 | N2007EPST0001149 |
原文获取